MedPath

To compare the efficacy of 2 standard anti-epileptic drugs valproate and levetiracetam in status epilepticus among elderly

Phase 4
Conditions
Health Condition 1: null- Patients with status epilepticus
Registration Number
CTRI/2016/05/006932
Lead Sponsor
ON FUNDED
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

•Patients with GCSE (more than 10 minutes of continuous convulsive seizure activity or two or more sequential seizures without full recovery of consciousness in between seizures), irrespective of etiology.

•Willing to participate.

•Age group more than 60 years.

Exclusion Criteria

•Not willing accompanying relatives/friends

•Patients having non-convulsive SE

•Liver failure, renal failure, cardiac disease (based on clinical judgment, available lab reports, ECG at presentation)

•Requiring urgent neurosurgical intervention.

•H/O allergy to drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Control of seizuresTimepoint: Control of seizures will be assessed in each subjects as soon as the study drug infusion is over. Subject will be continuously reassessed till primary outcome is arrived at.
Secondary Outcome Measures
NameTimeMethod
Mortality and MorbidityTimepoint: Recruitment to 1 month
© Copyright 2025. All Rights Reserved by MedPath